噬菌体治疗耐药性幽门螺杆菌的研究进展  

Advances of phage therapy in antibiotic-resistant Helicobacter pylori infection

作　　者：熊婧[1] 白杨[1] 

机构地区：[1]南方医科大学南方医院消化内科,广东广州510515

出　　处：《胃肠病学和肝病学杂志》2011年第6期586-588,共3页Chinese Journal of Gastroenterology and Hepatology

摘　　要：幽门螺杆菌感染是胃癌重要致病因子。目前,幽门螺杆菌对抗生素耐药情况日趋普遍。噬菌体治疗作为一种生物疗法在治疗幽门螺杆菌方面有极大的潜力。本文就噬菌体治疗耐药性幽门螺杆菌的现状及趋势进行综述。Helicobacter pylori （H. pylori） infection is one of the most important risk factors leading to gastric cancer. To date, it has been more and more popular that H. pylori is resistant to antibiotics. Phage therapy has a great advantages in control of H. pylori infection. In this article, we will review the advance of phage therapy in antibiotic-resistant H. pylori infection.

关 键 词：噬菌体疗法 幽门螺杆菌 抗生素耐药 

分 类 号：R573[医药卫生—消化系统]